UE LifeSciences

iBreastExam is a rapid diagnostic for early-stage detection of breast abnormalities.

Product description Brand name and product description

iBreastExam is a low cost, battery-powered, handheld rapid diagnostic device used for the identification of breast abnormalities and early detection of breast cancer. The device is radiation-free and is non-invasive. The product is being commercially distributed in over 25 countries across Africa and South Asia.

Target region(s) Target region for distribution/implementation (listed by country if specified)

The product is currently commercially available in Mexico, Nepal, Oman, Indonesia, India, Myanmar, and Botswana, and will be available in more African and South Asian countries in the future.

Distributors/implementing organizations Organization(s) distributing/deploying this product directly to communities/individuals?"

GE Healthcare is the primary distributor. iBreastExam has partnered with 40+ private clinics, governmental institutions, non-profits, and corporate social responsibility initiatives to enable the use of the product and breast examinations.

Market suggested retail price Price per unit or service price per usage/terms (USD). Subsidies noted.

10,000 USD

Furthermore, each scan costs between 1-4 USD.

Competitive landscape Similar products available on the market. May not be a comprehensive listing.

A primary competitor of this product is the Pink Drive, a mobile breast check service. The additional technological competition includes mammograms, ultrasounds, x-ray, and physical examination.

SDG targeted United Nations Sustainable Development Goals (SDGs) targeted with this product/application/service

Goal 3: Good health and well-being

Target user(s) Target user/consumer base (country, income segment)

Health care workers at primary care locations such as a doctor’s clinic, community health centers, health camps, or a hospital’s out-patient department.​

The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects https://t.co/MlRH1H0x2F